2-(1,3-Dioxoisoindolin-2-yl)-N-(3-methylisoxazol-5-yl)acetamide

Catalog No. :
ACIKDU761
CAS No. :
1049291-84-0
Molecular Formula :
C14H11N3O4
Molecular Weight :
285.26

IUPAC Name:2-(1,3-dioxoisoindolin-2-yl)-N-(3-methylisoxazol-5-yl)acetamide

2-(1,3-Dioxoisoindolin-2-yl)-N-(3-methylisoxazol-5-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$560.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1,3-Dioxoisoindolin-2-yl)-N-(3-methylisoxazol-5-yl)acetamide
IUPAC Name2-(1,3-dioxoisoindolin-2-yl)-N-(3-methylisoxazol-5-yl)acetamide
Molecular FormulaC14H11N3O4
Molecular Weight285.26
SMILESO=C(NC1=CC(C)=NO1)CN(C(C2=C3C=CC=C2)=O)C3=O
InChI KeyGPEUJUMJAQKDDL-UHFFFAOYSA-N
Synonym2-(1,3-Dioxoisoindolin-2-yl)-N-(3-methylisoxazol-5-yl)acetamide;2H-Isoindole-2-acetamide, 1,3-dihydro-N-(3-methyl-5-isoxazolyl)-1,3-dioxo-
CAS No.1049291-84-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACIKDU761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNUQK726 route compound structure diagram
    ACNUQK72614678-02-5 In Stock
  2. Plus
  3. ACBWTR078 route compound structure diagram
    ACBWTR0784702-13-0 In Stock
  4. Then
  5. ACIKDU761 route product structure diagram
    ACIKDU7611049291-84-0
Inquiry

2. ACIKDU761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNUQK726 route compound structure diagram
    ACNUQK72614678-02-5 In Stock
  2. Plus
  3. ACPJNK520 route compound structure diagram
    ACPJNK5206780-38-7 In Stock
  4. Then
  5. ACIKDU761 route product structure diagram
    ACIKDU7611049291-84-0
Inquiry

Comments (0)